Hemodialysis Complication Clinical Trial
Official title:
Effect of Triflow Breathing Training on Heart Rate Variability, Anxiety and Quality of Life in Hemodialysis Patients : A Randomized Control Trial
NCT number | NCT05809765 |
Other study ID # | N202001049 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 16, 2020 |
Est. completion date | May 14, 2021 |
Verified date | April 2023 |
Source | Taipei Medical University WanFang Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aims to explore whether an 8-week Triflow breath training program reduced the anxiety levels and improved the heart rate variability and quality of life of patients receiving hemodialysis. To investigate the effect of the triflow respiration training on the improvement of heart rate variability, anxiety, and the quality of life in hemodialysis patients.
Status | Completed |
Enrollment | 63 |
Est. completion date | May 14, 2021 |
Est. primary completion date | May 14, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: 1. Long-term hemodialysis is required to treat patients with end-stage renal disease diagnosed by a physician. 2. Blood older than or equal to 65 years old and under 80 years old with diabetes Dialysis patients. 3. Hemodialysis has been accepted for more than three months and is still under treatment and half There were no hospitalizations for other comorbidities during the year. 4. Those who are conscious and have no serious mental symptoms, can talk and express and agree to Subject to respirator training and questionnaires. 5. Available country and Taiwanese communicators. 6. The average score of the Situational Trait Anxiety Scale is greater than 20 points. Exclusion Criteria: 1. Patients with low blood pressure during dialysis can not raise the bed to 30 degrees. 2. Blindness and hearing or long-term bedridden. 3. There are cases of irregular heartbeat. 4. The Daily Activity Scale is less than or equal to 60 points (the study uses the Barthel Index). |
Country | Name | City | State |
---|---|---|---|
Taiwan | Taipei Medical University | Taipei |
Lead Sponsor | Collaborator |
---|---|
Taipei Medical University WanFang Hospital |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes of heart rate variability, the measurement indices were the total power, which reflects the autonomic tone; the low-frequency component of heart rate variability. | The heart rate variability was measured using the 60601-1 program provided by Daily Care BioMedical, and the balance of their autonomic nervous systems was analyzed using the 60601-1 software. | For the experimental group, heart rate variability was measured each week during the 8-week breath training. For the control group, heart rate variability was measured at the first, 4th and the 8th week. | |
Primary | Changes of the level of anxiety | The State-Trait Anxiety Inventory (STAI) is used to measure the levels of anxiety. It consists of two subscales: one for state anxiety and the other for trait anxiety. Each subscale comprises 20 items, rated using a 4-point Likert scale (1 = hardly; 2 = sometimes; 3 = often; and 4 = almost always), with a total score of 20-80. | The level of anxiety was measured at the first week, 4th week and the 8th week. | |
Primary | Changes of the level of quality of life | The Chinese version of World Health Organization Quality of Life Brief Edition (WHOQoL-BREF) was used, which consists of 28 items. All items are rated using a 5-point Likert scale. Each Quality of life dimension differs in the number of items, and its score is determined by multiplying the mean score of all its items by 4. The average score of each dimension ranges from 4 to 20, with a higher score indicating a better Quality of life. | The level of quality of life was measured at the first week, 4th week and the 8th week. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05980845 -
The Effect Nature Sounds and Music on Hemodialysis Patients
|
N/A | |
Recruiting |
NCT05020717 -
Retrospective Survey of Hyperkalemia in Hemodialysis
|
||
Recruiting |
NCT04046042 -
Virtual Reality Intradialysis: Last vs. First Part of the Session
|
N/A | |
Recruiting |
NCT04094038 -
The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients
|
Phase 4 | |
Completed |
NCT03311581 -
The Feasibility of Propofol TCI in Hemodialysis Patients Undergoing Arteriovenous Shunt Surgery
|
Phase 1 | |
Completed |
NCT05531175 -
REIKI APPLICATION PAIN, FATIGUE AND ITCHING IN HEMODIALYSIS PATIENTS
|
N/A | |
Completed |
NCT04057313 -
Coffee in Hemodialysis and Headache
|
N/A | |
Completed |
NCT03061552 -
Inferior Vena Cava Sonography in Hemodialysis Patients and Quality of Life
|
N/A | |
Completed |
NCT03251573 -
The Cohort Study of Cognitive Impairment in Chinese Hemodialysis Patients
|
||
Completed |
NCT05568342 -
The Effect of Roy Adaptation-Based Nursing Intervention
|
N/A | |
Completed |
NCT03527680 -
Effect of Lactobacillus Rhamnosus on Serum Uremic Toxins in Hemodialysis
|
N/A | |
Completed |
NCT04063423 -
Non- Clinical Coagulation Activation During Hemodialysis
|
||
Active, not recruiting |
NCT06203795 -
Dialysis Performance of the FX CorAL Membrane
|
N/A | |
Completed |
NCT04319328 -
Is Cefazolin, Ceftazidime and Ciprofloxacin Dosing Optimal in Hemodialysis Patients?
|
||
Completed |
NCT03627884 -
Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation
|
Phase 4 | |
Completed |
NCT05132036 -
Lung Ultrasound Assessment of Fluid Overload in Haemodialysis Patients
|
N/A | |
Completed |
NCT03076528 -
An Innovative Virtually Supervised Exercise for Dialysis Patients
|
Phase 2 | |
Completed |
NCT06098443 -
Acupressure Versus Transcutaneous Electrical Nerve Stimulation on Pain and Quality of Life Intradialysis
|
N/A | |
Completed |
NCT04645121 -
Carbon Monoxide-based Rebreathing Method and Bioimpedance in Hemodialysis Patients
|
||
Recruiting |
NCT04127877 -
Bio Impedance-assisted Monitoring of Chronic Hemodialysis Patients
|
N/A |